Europe Nasal Drug Delivery Technology Market Size & Outlook

The nasal drug delivery technology market in Europe is expected to reach a projected revenue of US$ 35,910.8 million by 2030. A compound annual growth rate of 7.4% is expected of Europe nasal drug delivery technology market from 2024 to 2030.
Revenue, 2023 (US$M)
$21,752.6
Forecast, 2030 (US$M)
$35,910.8
CAGR, 2024 - 2030
7.4%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe nasal drug delivery technology market, 2018-2030 (US$M)

Europe nasal drug delivery technology market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe nasal drug delivery technology market highlights

  • The Europe nasal drug delivery technology market generated a revenue of USD 21,752.6 million in 2023.
  • The market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
  • In terms of segment, nasal sprays was the largest revenue generating dosage form in 2023.
  • Nasal Drops is the most lucrative dosage form segment registering the fastest growth during the forecast period.
  • Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.

Europe data book summary

Market revenue in 2023USD 21,752.6 million
Market revenue in 2030USD 35,910.8 million
Growth rate7.4% (CAGR from 2023 to 2030)
Largest segmentNasal sprays
Fastest growing segmentNasal Drops
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNasal Sprays, Nasal Drops, Nasal Gels, Nasal Powders
Key market players worldwideAstraZeneca PLC, Pfizer Inc, OptiNose Inc, Becton Dickinson & Co, Dr Reddy's Laboratories Ltd ADR, GlaxoSmithKline, B.F. Ascher & Company, Pendopharm, Douglas Pharmaceuticals, ENT Technologies, Naveh Pharma

Other key industry trends

  • In terms of revenue, Europe region accounted for 28.3% of the global nasal drug delivery technology market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 45,686.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nasal Drug Delivery Technology Market Companies

Name Profile # Employees HQ Website
Naveh Pharma View profile 1-10 Netanya, HaMerkaz, Israel, Asia http://www.navehpharma.com/
ENT Technologies View profile 11-50 Hawthorn, Victoria, Australia, Oceania https://www.flo.com.au/
Douglas Pharmaceuticals View profile 501-1000 Auckland, Auckland, New Zealand, Oceania http://www.douglas.co.nz/
Pendopharm View profile 1001-5000 Montreal, Quebec, Canada, North America http://pendopharm.com
B.F. Ascher & Company View profile 1-10 Shawnee Mission, Kansas, United States, North America https://www.bfascher.com/
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
OptiNose Inc View profile 132 1020 Stony Hill Road, Suite 300, Yardley, PA, United States, 19067 https://www.optinose.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Dr Reddy's Laboratories Ltd ADR View profile 22822 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 https://www.drreddys.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com

Europe nasal drug delivery technology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nasal drug delivery technology market will help companies and investors design strategic landscapes.


Nasal sprays was the largest segment with a revenue share of 39.19% in 2023. Horizon Databook has segmented the Europe nasal drug delivery technology market based on nasal sprays, nasal drops, nasal gels, nasal powders covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe Nasal Drug Delivery Technology Dosage Form Outlook (Revenue, USD Million, 2018-2030)
    • Nasal Drops
    • Nasal Gels
    • Nasal Powders
    • Nasal Sprays
  • Europe Nasal Drug Delivery Technology Container Type Outlook (Revenue, USD Million, 2018-2030)
    • Pressurized Containers
    • Non-pressurized containers
  • Europe Nasal Drug Delivery Technology Application Outlook (Revenue, USD Million, 2018-2030)
    • Others
    • Nasal Congestion
    • Rhinitis
    • Asthma

Reasons to subscribe to Europe nasal drug delivery technology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe nasal drug delivery technology market databook

  • Our clientele includes a mix of nasal drug delivery technology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe nasal drug delivery technology market , including forecasts for subscribers. This continent databook contains high-level insights into Europe nasal drug delivery technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe nasal drug delivery technology market size, by country, 2018-2030 (US$M)

Europe Nasal Drug Delivery Technology Market Outlook Share, 2023 & 2030 (US$M)

Europe nasal drug delivery technology market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online